Literature DB >> 21253810

Single oligoarray-based detection of specific M918T mutation in RET oncogene in multiple endocrine neoplasia type 2B.

R A Pacheco-Rivera1, E Hernández-Zamora, B González-Yebra, K Beattie, R Maldonado-Rodríguez, J C Santiago-Hernández, M E Medrano-Ortiz de Zárate, M Salcedo.   

Abstract

The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene (ATG → ACG). The aim of this work was to develop a single oligoarray by using tandem hybridization to detect the T918C/RET mutation for MEN 2B patients. Two genetically non-related families were studied; each family had a member affected by MEN2B. Both patients presented the T918C/RET mutation in a heterozygous fashion. None of the relatives was positive for this mutation; thus, these cases arose de novo. The proper mutation was confirmed by with different tools, PCR-Fok I endonuclease, direct sequencing, and also using our oligoarray. In this case, it is suitable to use a DNA target smaller than 150 bases with single- or double-stranded DNA and short probes of 7-mer. It was also possible to detect the mutation by employing different sources of DNA, fresh or paraffin-embedded tissues. Therefore, the present oligoarray can identify the most common M918T mutation of RET oncogene from a variety of DNA sources with good specificity and be a good alternative in the molecular diagnosis for MEN 2B cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21253810     DOI: 10.1007/s10238-010-0128-z

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  25 in total

1.  A high-density probe array sample preparation method using 10- to 100-fold fewer cells.

Authors:  M Mahadevappa; J A Warrington
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

Review 2.  Exploring the new world of the genome with DNA microarrays.

Authors:  P O Brown; D Botstein
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 3.  Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.

Authors:  C Eng; L M Mulligan
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

4.  RET oncogene mutations in medullary thyroid carcinoma in Mexican families.

Authors:  Beatriz González; Mauricio Salcedo; María Elena Medrano; Alejandra Mantilla; Guadalupe Quiñónez; Luis Benítez-Bribiesca; Sergio Rodríguez-Cuevas; Lourdes Cabrera; Beatriz de León; Nelly Altamirano; José Tapia; Brian Dawson
Journal:  Arch Med Res       Date:  2003 Jan-Feb       Impact factor: 2.235

5.  An oligoarray for the detection of human papillomavirus type 16 variants.

Authors:  P Mendoza-Lorenzo; R Maldonado; R Pacheco; A Méndez; P Piña-Sánchez; A Rangel; G Vazquez-Ortíz; M Salcedo
Journal:  Int J Gynecol Cancer       Date:  2007 Sep-Oct       Impact factor: 3.437

6.  Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.

Authors:  L M Mulligan; D J Marsh; B G Robinson; I Schuffenecker; J Zedenius; C J Lips; R F Gagel; S I Takai; W W Noll; M Fink
Journal:  J Intern Med       Date:  1995-10       Impact factor: 8.989

7.  Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families.

Authors:  M Rossel; I Schuffenecker; M Schlumberger; C Bonnardel; E Modigliani; P Gardet; J Navarro; Y Luo; G Romeo; G Lenoir
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

8.  Presence of the 918 mutation in the RET proto-oncogene in a Mexican patient with multiple endocrine neoplasia type 2B.

Authors:  A Hidalgo; M E Medrano; S Rodrìguez; C Franco; I Martinez; L Benítez; M Salcedo
Journal:  J Exp Clin Cancer Res       Date:  1998-06

Review 9.  RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Expert Rev Anticancer Ther       Date:  2008-04       Impact factor: 4.512

10.  Low density DNA microarray for detection of most frequent TP53 missense point mutations.

Authors:  Angélica Rangel-López; Rogelio Maldonado-Rodríguez; Mauricio Salcedo-Vargas; Juana Mercedes Espinosa-Lara; Alfonso Méndez-Tenorio; Kenneth L Beattie
Journal:  BMC Biotechnol       Date:  2005-02-15       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.